Haplo-stem cell transplant post liver transplantation to cure sickle cell disease with related liver dysfunction: a case series
Dual haplo-HCT and living donor liver transplantation (LDLT) is feasible in eligible SCD patients with end-stage liver disease.
Authors
- Saleh A. Alqahtani (ORCID: https://orcid.org/0000-0003-2017-3526)
- Dieter Broering (ORCID: https://orcid.org/0000-0003-0422-0409)
- Hadeel Samarkandi (ORCID: https://orcid.org/0000-0003-2891-7083)
- Ali D Alahmari (ORCID: https://orcid.org/0000-0002-7577-0152)
- Waleed Al-hamoudi (ORCID: https://orcid.org/0000-0002-2759-0894)
- Adetola A. Kassim (ORCID: https://orcid.org/0000-0002-0484-5903)
- Saad Alghamdi (ORCID: https://orcid.org/0000-0003-4532-9128)
- Reem Alasbali (ORCID: https://orcid.org/0000-0002-7464-3637)
- Hazzaa Alzahrani (ORCID: https://orcid.org/0000-0002-5596-8807)
- Mahmoud Aljurf (ORCID: https://orcid.org/0000-0003-3942-7370)
- Sara Samarkandi
- Syed Osman Ahmed
- Fahad Almohareb (ORCID: https://orcid.org/0000-0003-3992-1846)
Institutions
- Vanderbilt University (US)
- King Faisal Specialist Hospital & Research Centre (SA)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Communications Medicine
- Published
- 2025-08-15
- DOI
- https://doi.org/10.1038/s43856-025-01040-0
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Imperial College London
- King's College London
- King Faisal Specialist Hospital and Research Centre